Skip to main content

Bicycle Therapeutics PLC

BCYC
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001761612

No open-market purchases or sales by Bicycle Therapeutics PLC insiders were filed in the last 90 days; 103 institutions reported holding it in 13F filings for Q2 2026, worth $157.9M in total; no superinvestor holds it.

Q3 2025 vs. Q2 2025

How the institutions holding Bicycle Therapeutics PLC changed between Q2 2025 and Q3 2025.

All holders in Q3 2025All holders in Q2 2025

13F holders of BCYC: Q2 2025 compared with Q3 2025
MeasureQ2 2025Q3 2025Change
Holders11099−11
Shares41.2M36.9M−4.29M (−10.4%)
Value$286.3M$285.6M−$718.9K (−0.3%)

New holders (10)

Institutions that held Bicycle Therapeutics PLC at the end of Q3 2025 but not at the end of Q2 2025.

Institutions new to BCYC in Q3 2025
InstitutionSharesValue% of portfolio
Birchview Capital, LP154,000$1.19M0.90%
State of New Jersey Common Pension Fund D20,105$155.6K0.00%
JustInvest LLC12,953$100.3K0.00%
XTX Topco Ltd11,648$90.2K0.00%
FNY Investment Advisers, LLC10,500$81.0K0.03%
Commonwealth of Pennsylvania Public School Empls Retrmt Sys10,116$78.3K0.00%
Walleye Trading LLC630$4.88K0.00%
EverSource Wealth Advisors, LLC6$460.00%
Rockefeller Capital Management L.P.5$390.00%
Caitlin John, LLC2$150.00%

Sold out (21)

Institutions that held Bicycle Therapeutics PLC at the end of Q2 2025 and filed for Q3 2025 without it.